PCM
TCON

Prelude Capital Management’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Prelude Capital Management’s Portfolio TCON Stock Details TCON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1
Closed -$2K – 1735
2015
Q3 		$2K Buy
+1
New +$2.34K ﹤0.01% 1435
2015
Q2 		– Sell
-1
Closed -$1K – 2107
2015
Q1 		$1K Buy
+1
New +$2.63K ﹤0.01% 1899

Other funds holding TCON

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WG
Welch Group Birmingham, Alabama $2.66B AUM 14.89% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Prelude Capital Management's TCON Position: Q4 2015 in Review

Prelude Capital Management sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q4 2015, closing a stake of 1 share — an estimated $2K sold.

Prelude Capital Management first reported a position in TCON in Q1 2015 and held it in 2 quarters. The position peaked at $2K in Q3 2015. 23 funds tracked by Wall St. Rank hold TCON as of Q4 2015.

  • Prelude Capital Management reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • Prelude Capital Management sold 1 TRACON Pharmaceuticals, Inc. Common Stock share in Q4 2015, an estimated $2K.
  • Prelude Capital Management first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q1 2015 and held it in 2 quarters.
  • Prelude Capital Management's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $2K in Q3 2015.
  • 23 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q4 2015.

Based on Prelude Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.